Omega-3 Fatty Acids and Glaucoma Risk
omega-3 fatty acid supplementation may significantly lower the risk of developing glaucoma in individuals with dry eye disease.
Researchers analyzed data from 14,168 adult patients across a multinational database between 2013 and 2023. They compared a group prescribed omega-3 supplements against a matched control group over a five-year follow-up period.
Key Findings
Compared to the control group, patients who received omega-3 supplements experienced substantially lower risks across multiple conditions:
Total Glaucoma: Risk reduced by 52% (HR: 0.48)
Primary Open-Angle Glaucoma (POAG): Risk reduced by 55% (HR: 0.45)
Normal-Tension Glaucoma (NTG): Risk reduced by 59% (HR: 0.41)
Ocular Hypertension: Risk reduced by 43% (HR: 0.57)
Primary Angle-Closure Glaucoma (PACG): Risk reduced by 55% (HR: 0.45)
First-Line Glaucoma Medication Use: Risk reduced by 35% (HR: 0.65)
Biological Mechanisms & Next Steps
The protective benefits remained consistent across various demographics, including women, individuals aged 60 or older, and Caucasian populations. Researchers highlight that omega-3s potentially decrease risk by:
Lowering intraocular pressure (IOP)
Enhancing blood flow to the eyes
Providing neuroprotection to retinal ganglion cells
Mitigating inflammation and oxidative stress
Note: While these findings indicate that omega-3 intake could complement current preventative strategies, the authors emphasize that randomized controlled trials are still necessary to confirm direct causality and establish optimal dosages.
Comments
Post a Comment
Leave a Comment or Question: